Your browser doesn't support javascript.
loading
LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington's Disease.
Chopra, Vanita; Quinti, Luisa; Khanna, Prarthana; Paganetti, Paolo; Kuhn, Rainer; Young, Anne B; Kazantsev, Aleksey G; Hersch, Steven.
Afiliação
  • Chopra V; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA, USA.
  • Quinti L; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA, USA.
  • Khanna P; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA, USA.
  • Paganetti P; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Kuhn R; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Young AB; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA, USA.
  • Kazantsev AG; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA, USA.
  • Hersch S; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA, USA.
J Huntingtons Dis ; 5(4): 347-355, 2016 12 15.
Article em En | MEDLINE | ID: mdl-27983565
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Huntington / Fármacos Neuroprotetores / Inibidores de Histona Desacetilases / Ácidos Hidroxâmicos / Indóis Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Huntington / Fármacos Neuroprotetores / Inibidores de Histona Desacetilases / Ácidos Hidroxâmicos / Indóis Idioma: En Ano de publicação: 2016 Tipo de documento: Article